Clinical trial
Metabolic Surgery for the Treatment and Understanding of Non-Alcoholic Steato-Hepatitis (NASH): Weight-Dependent and Weight-Independent Effects
NCT04282005 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Surgery for the Treatment and Understanding of Non-Alcoholic Steato-Hepatitis (NASH): Weight-Dependent and Weight-Independent Effects
- Lead sponsor
- King's College London
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 13, 2020
- Completion date
- January 1, 2022
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-alcoholic fatty liver disease (nafld), non-alcoholic steato-hepatitis (nash)